✦ LIBER ✦

PMD1 Economic Value of Screening for Early Parkinson's Disease in a European Setting

✍ Scribed by S. Johnson; H.G. Birnbaum; A. Kaltenboeck; M. Diener; A. Siderowf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND17 Economic Value of Screening for Ea

✍ S. Johnson; A. Siderowf 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Commentary on “Health economics and the

✍ Bruno Vellas; Lutz Froelich; C. Sampaio 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Development and validation of a new scre

✍ Simons, Janine A.; Fietzek, Urban M.; Waldmann, Annika; Warnecke, Tobias; Schust 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 614 KB

PND25 EVALUATION OF A BRIEF DEMENTIA SCR

✍ I Andrés; J Kulisevsky; M Balañä; J Pagonabarraga; G Llebaria; AL Gobartt; J Arr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Screening PARK genes for mutations in ea

✍ George D. Mellick; Gerhard A. Siebert; Manabu Funayama; Daniel D. Buchanan; Yuan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 253 KB

PND20 Cost Effectiveness of Rasagiline a

✍ M. Pizarro; A. Rizzoli; G. Salmeron; N. Gonzalez; H. Soto 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB